We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$63.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$56.6M
3
AEM icon
Agnico Eagle Mines
AEM
+$55.1M
4
DFS
Discover Financial Services
DFS
+$36M
5
ORBC
ORBCOMM, Inc.
ORBC
+$27.5M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DORM icon
2826
Dorman Products
DORM
$4.18B
$11K ﹤0.01%
122
– –
EBIZ icon
2827
Global X E-commerce ETF
EBIZ
$29.5M
$11K ﹤0.01%
394
-102
-21% -$3.27K
FFA
2828
First Trust Enhanced Equity Income Fund
FFA
$467M
$11K ﹤0.01%
571
+9
+2% +$187
FQAL icon
2829
Fidelity Quality Factor ETF
FQAL
$1.46B
$11K ﹤0.01%
+223
New +$11.4K
FVAL icon
2830
Fidelity Value Factor ETF
FVAL
$1.38B
$11K ﹤0.01%
+231
New +$11.4K
GTBP icon
2831
GT Biopharma
GTBP
$11.5M
$11K ﹤0.01%
57
– –
GTES icon
2832
Gates Industrial Corporation Ltd.
GTES
$7.15B
$11K ﹤0.01%
+698
New +$11.9K
HIMS icon
2833
Hims & Hers Health
HIMS
$7.31B
$11K ﹤0.01%
1,500
– –
HPI
2834
John Hancock Preferred Income Fund
HPI
$433M
$11K ﹤0.01%
512
+10
+2% +$217
HRTX icon
2835
Heron Therapeutics
HRTX
$92.9M
$11K ﹤0.01%
1,100
-110
-9% -$1.34K
IEO icon
2836
iShares US Oil & Gas Exploration & Production ETF
IEO
$543M
$11K ﹤0.01%
192
+42
+28% +$2.19K
IGA
2837
Voya Global Advantage and Premium Opportunity Fund
IGA
$158M
$11K ﹤0.01%
1,130
– –
JOF
2838
Japan Smaller Capitalization Fund
JOF
$350M
$11K ﹤0.01%
1,324
-6,927
-84% -$63K
KF
2839
Korea Fund
KF
$246M
$11K ﹤0.01%
275
– –
L icon
2840
Loews
L
$23.6B
$11K ﹤0.01%
216
+148
+218% +$8.04K
ONCY
2841
Oncolytics Biotech
ONCY
$95.8M
$11K ﹤0.01%
5,540
– –
PFG icon
2842
Principal Financial Group
PFG
$24.3B
$11K ﹤0.01%
175
-87
-33% -$5.59K
RYAN icon
2843
Ryan Specialty Holdings
RYAN
$11B
$11K ﹤0.01%
+350
New +$11K
SID icon
2844
Companhia Siderúrgica Nacional
SID
$1.23B
$11K ﹤0.01%
+2,249
New +$16.9K
SIGI icon
2845
Selective Insurance
SIGI
$5.73B
$11K ﹤0.01%
156
-9
-5% -$725
UFPI icon
2846
UFP Industries
UFPI
$5.19B
$11K ﹤0.01%
164
-1,518
-90% -$110K
ZIP icon
2847
ZipRecruiter
ZIP
$423M
$11K ﹤0.01%
+429
New +$11.1K
SMC
2848
Summit Midstream
SMC
$419M
$11K ﹤0.01%
315
– –
ENLC
2849
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$11K ﹤0.01%
1,660
+28
+2% +$164
VTRU
2850
DELISTED
Vitru Limited Common Shares
VTRU
$11K ﹤0.01%
700
– –
112 113
114
115 116

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.